Clinical Trial Update: Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating extending lamivudine therapy in chronic hepatitis B patients after 3 years of oral antiviral treatment. The status of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Lamivudine (lamivudine)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN